Episode 38 - Obesity and What it Means for Plan Sponsors
27m
·
HR Benecast
·
Nearly half of working Americans have obesity, raising the risk of Type 2 diabetes, heart disease and stroke. Hear from George Huntley, founding member and CEO of the Diabetes Leadership Council, about the importance of addressing obesity and the role it plays in employee retention. He'll share successful treatment options and the direct and indirect benefits for plan sponsors and their participants.
The episode Episode 38 - Obesity and What it Means for Plan Sponsors from the podcast HR Benecast has a duration of
27:23. It was first published
More episodes from HR Benecast
Episode 43 - Pharmacy Benefits Legislation
In this episode, we're joined by Madison Connor, senior vice president of regulatory compliance and external affairs at Employers Health. She will share the latest in state and federal PBM legislation. Hear who's behind many of the recent PBM legislative initiatives, how PBMs like CVS and Optum Rx plan to handle these newly-proposed state laws and discover how employers can prepare for these new requirements.
Episode 42 - Fiduciary Duties: A Wakeup Call
Hear from employee benefits and compensation lawyer Jeff Zimon as he covers why fiduciary obligations are making headlines and what the Johnson & Johnson lawsuit means for plan sponsors. He discusses steps employers can take to ensure they are fulfilling their fiduciary duties, the importance of summary plan descriptions (SPDs) and the need for proper pharmacy benefit documentation.
Episode 41 - The Latest in GLP-1s for Employers and Consultants
The first 2024 episode of HR Benecast featuresCourtney Keefe, Employers Health's resident GLP-1 expert. She'll share utilization, discontinuation and coverage trends for GLP-1s and anti-obesity drugs. Listeners will hear the latest on anti-obesity drug coverage under the pharmacy benefit, new drugs in the pipeline and how the big PBM's are managing drugs like Wegovy, Mounjaro and Zepbound.
Episode 40 - Stop Loss and Catastrophic Claimant Risk Management
On our last episode of 2023, we sit down withRyan Siemers, founder and principal at Aegis Risk to cover all the intricacies of stop loss. As the costs of catastrophic claims continue to grow, reinsurance protection and medical stop loss are more important than ever. Listen to hear how costly gene therapies are impacting deductibles, potential health care industry changes could drive prices even higher and more.
To learn more about the Aegis Risk Medical Stop Loss Premium Survey visit https://www.aegisrisk.com/copy-of-stop-loss-premium-survey-header and to register to hear Ryan Siemers presentation on Medical Stop Loss & Risk Strategies for Catastrophic Claimants please visit https://www.employershealthco.com/resource-center/events/abf24/.
Episode 39 - What Should Employers Know About Pharmacogenomics?
In this episode of HR Benecast, we're joined by Travis Baughn, vice president of clinical solutions at Optum Rx. Listen to hear how pharmacogenetics works and its importance for employers. He'll share what plan participants need to know, and how it can be used to reduce medical waste and long and complex medication journeys.
For additional resources on pharmacogenomics, please visit cpicpgx.org and pharmgkb.org.